‘Supplement’ On CBD Product Label A Bullseye For US Litigants, Says Attorney

Two CBD marketers warned by FDA in a recent crackdown are targeted in class action complaints alleging they made unsubstantiated health claims and mislabeled ‘illegal drug’ products as supplements. Complaints are a wake-up call to CBD wellness industry to ensure claims are substantiated, as the class action bar is on the prowl following the agency’s 15 warning letter blast in November.

Companies selling cannabiniod-containing products advertised as supplements or bearing a Supplement Facts label are at higher risk of being targeted in complaints for damages, suggests food and drug attorney Frederick Ball.

At least hundreds of CBD-containing products have been sold in the US over the past few years without spurring attention...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Regulation

More from Policy & Regulation